Hui Quan - Concepedia

Author

Hui Quan

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

H Quan, H. Quan, HUI QUAN, Hongmin Quan, Hui Quan, Quan, Hui, Riddell, Robert

139

Publications

10.9K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Sanofi (United States)United States Military Academy Novartis (United States)Rutgers, The State University of New Jersey

About

Hui Quan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, statistics, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.8K
2	Health Sciences	8	8	485
3	Engineering	5	5	137
4	Public Health	4	4	142
5	Arts	1	1	79

Hui Quan

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial Robert S. Bresalier, Robert S. Sandler, Hui Quan, New England Journal of Medicine	2005	2.5K
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis Uri Liberman, Stuart Weiss, Johann Bröll, New England Journal of Medicine	1995	2.3K
Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids Francesca Catella-Lawson, Brendan McAdam, Briggs Morrison, Journal of Pharmacology and Experimental Therapeutics	1999	595
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis Loren Laine, S. E. Harper, Thomas Simon, Gastroenterology Anti-inflammatoryGastrointestinal PharmacologyCyclooxygenase 2–SpecificMedicineChronic Musculoskeletal Condition	1999	476
A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas John A. Baron, Robert S. Sandler, Robert S. Bresalier, Gastroenterology Chemoprevention StrategyGastroenterologyColorectal CancerPathologyRandomized Trial	2006	431
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial Christopher J. Hawkey, Loren Laine, Thomas Simon, Arthritis & Rheumatism	2000	365
Functional Interaction between Monoamine Plasma Membrane Transporters and the Synaptic PDZ Domain–Containing Protein PICK1 Gonzalo E. Torres, Wei-Dong Yao, Amy R. Mohn, Neuron Synaptic PlasticityMolecular NeuroscienceBiochemistrySynaptic TransmissionNeurotransmitter	2001	341
Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet Suzanne K. Swan, David W. Rudy, Kenneth C. Lasseter, Annals of Internal Medicine	2000	336
Studies of the oral bioavailability of alendronate* Barry J. Gertz, Sherry D. Holland, W. F. Kline, Clinical Pharmacology & Therapeutics Oral BioavailabilityGastric PhMetabolic Bone DiseaseMedicineClinical Nutrition	1995	258
Mice Deficient for the Vesicular Acetylcholine Transporter Are Myasthenic and Have Deficits in Object and Social Recognition Vânia F. Prado, Cristina Martins-Silva, Braulio M. de Castro, Neuron Knockout MouseMolecular NeuroscienceSocial RecognitionNeuroanatomySynaptic Transmission	2006	246

Page 1